Hill, Mitch C.'s Form 4 filing
Inari Medical, Inc. (NARI) · filed Feb 15, 2023
- Accession no.
- 0001127602-23-005365
- Filed
- Feb 15, 2023, 4:43 PM ET
- Trade date
- Feb 13, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $686.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hill, Mitch C.CIK 0001644989 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2023 | Common Stock | MOption exerciseAcquired | +6,500 | $0.457 | +$2,970.5 | 59,230 | Direct | |
| Feb 13, 2023 | Common Stock | SSaleDisposed | −5,486 | $53.76F2 | −$294,927.36 | 53,744 | Direct | |
| Feb 13, 2023 | Common Stock | SSaleDisposed | −1,014 | $54.11F3 | −$54,867.54 | 52,730 | Direct | |
| Feb 13, 2023 | Common Stock | SSaleDisposed | −5,647 | $53.78F4 | −$303,695.66 | 47,083 | Direct | |
| Feb 13, 2023 | Common Stock | SSaleDisposed | −603 | $54.15F5 | −$32,652.45 | 46,480 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2023 | Common Stock | MOption exerciseDisposed | −6,500 | $0.00 | $0 | 159,477 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $53.03 to $54.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $54.03 to $54.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $53.08 to $54.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $54.10 to $54.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.